EUCTR2021-005766-18-FRActive, not recruitingPhase 1
ORAL GLIBENCLAMIDE IN HYPERGLYCAEMIA IN PREMATURE
Assistance Publique – Hôpitaux de Paris (AP-HP), par délégation : Direction de la Recherche Clinique et de l’Innovation0 sites45 target enrollmentStarted: May 17, 2024Last updated:
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 45
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 45
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 1
GALOP : Oral glibenclamide in hyperglycaemia of the premature infantCTIS2024-512230-15-00Assistance Publique Hopitaux De Paris45
Active, not recruiting
Phase 2
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)PretermGlibenclamide Adverse ReactionHypoglycemia, Neonatal TransientNCT05687500Assistance Publique - Hôpitaux de Paris35
Completed
Not Applicable
Therapeutic implications of oral hypoglycaemic agents on the enteroinsular axis in type 2 diabetesType 2 diabetesNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN37245053Royal Victoria Hospital (UK)40
Active, not recruiting
Phase 1
ow dose Glibenclamide in Diabetes - Part A (LEGEND-A)Type 2 diabetes mellitus.MedDRA version: 19.0 Level: PT Classification code 10012601 Term: Diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2015-002837-23-GBniversity of Oxford16
Completed
Not Applicable
Treatment of hyperglycemia in patients with acute intracerebral hemorrhage: A Randomised Pilot Study.intra-cerebral hemorrhage, diabetes mellitusJPRN-UMIN000010079Department of Stroke Medicine, Kawasaki Medical School100